Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

Learn how AI in drug discovery is revolutionizing therapeutic development and addressing challenges in cell and gene therapy.

California-based Creyon Bio has announced a global licensing and multi-target research collaboration with US pharma major Eli ...

Eli Lilly and Creyon Bio have entered into a partnership worth over $1bn to develop RNA-targeted oligonucleotide (oligo) ...

Creyon Bio, Inc. (Creyon) announced a global licensing and multi-target research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of novel ...

Creyon Bio, Inc. ("Creyon") today announced a global licensing and multi-target research collaboration with Eli Lilly and Company ("Lilly") focused on the discovery, development and commercialization ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

BigHat Biosciences, a biotechnology company, has entered a strategic collaboration with Eli Lilly and Company.

In this article, we are going to take a look at where Eli Lilly and Company ... In the summer of last year, Lilly secured FDA approval for its AD drug, Kisunla. While weight loss therapies ...

Drugmaker Eli Lilly(NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the announcement that its newest GLP-1 drug had successfully completed the ...